期刊
TALANTA
卷 184, 期 -, 页码 193-201出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.talanta.2018.03.002
关键词
Lipid peroxidation; Neurological damage; Urine; Mass spectrometry; Biomarker; Isoprostane; Isofuran
资金
- ISCIII (Spanish Ministry of Economy and Competitiveness) [CP16/00082]
- PN (Spain)
- ISCIII-Sub-Directorate General for Research Assessment and Promotion
- European Regional Development Fund (FEDER) [RD12/0026]
Lipid peroxidation plays an important role in Alzheimer Disease, so corresponding metabolites found in urine samples could be potential biomarkers. The aim of this work is to develop a reliable ultra-performance liquid chromatography-tandem mass spectrometry analytical method to determine a new set of lipid peroxidation compounds in urine samples. Excellent sensitivity was achieved with limits of detection between 0.08 and 17 nmol L-1, which renders this method suitable to monitor analytes concentrations in real samples. The method's precision was satisfactory with coefficients of variation around 5-17% (infra-day) and 8-19% (inter-day). The accuracy of the method was assessed by analysis of spiked urine samples obtaining recoveries between 70% and 120% for most of the analytes. The utility of the described method was tested by analyzing urine samples from patients early diagnosed with mild cognitive impairment or mild dementia Alzheimer Disease following the clinical standard criteria. As preliminary results, some analytes (17(RS)-10-epi-SC-Delta(15)-11-dihomo-IsoF, PGE(2)) and total parameters (Neuroprostanes, Isoprostanes, Isofurans) show differences between the control and the clinical groups. So, these analytes could be potential early Alzheimer Disease biomarkers assessing the patients' pro-oxidant condition.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据